How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey

International Journal of Clinical Oncology
Yoshihito YokoyamaDisease Committee of Uterine Cancer, Japanese Gynecologic Oncology Group

Abstract

This survey sought to determine Japanese gynecologists' attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Responses from 363 individuals (response rate 40.9 %) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternat...Continue Reading

References

Nov 1, 1986·Journal of Steroid Biochemistry·C F HolinkaE Gurpide
Nov 1, 1996·American Journal of Obstetrics and Gynecology·J A ChapmanM L Berman
Mar 29, 2001·Obstetrics and Gynecology·K A SurianoP J DiSaia
Jun 20, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·UNKNOWN Committee on Gynecologic Practice, The American College of Obstetricians and Gynecologists
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Aug 9, 2005·Lancet·Frederic AmantIgnace Vergote
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard R BarakatUNKNOWN Gynecologic Oncology Group Study
Apr 29, 2006·Menopause : the Journal of the North American Menopause Society·Femke AtsmaYvonne T van der Schouw
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanAtike Sever
Oct 3, 2006·The Lancet Oncology·Walter A RoccaL Joseph Melton
Apr 20, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S B Decruze, J A Green
Jul 11, 2009·Climacteric : the Journal of the International Menopause Society·S KilicS Batioglu
Jan 20, 2010·Climacteric : the Journal of the International Menopause Society·K HanckeD Denschlag
May 7, 2011·Climacteric : the Journal of the International Menopause Society·T YoshidaH Kurachi
Jun 24, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Denis QuerleuUNKNOWN Societe Francaise d'Oncologie Gynecologique
Jan 30, 2014·The Journal of Obstetrics and Gynaecology Research·Daisuke Aoki

❮ Previous
Next ❯

Citations

Mar 20, 2020·Journal of Cancer Research and Clinical Oncology·Louis JacobMatthias Kalder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Seung-Hyuk ShimSoo-Nyung Kim
Gynecologic Oncology
Yoh WatanabeDisease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group
Gynecologic Oncology
Yoh WatanabeDisease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group
European Journal of Gynaecological Oncology
Dimitrios VavilisBasil C Tarlatzis
© 2022 Meta ULC. All rights reserved